A Hidden Molecular Switch Could Change How We Treat Aggressive Prostate Cancer

Researchers have discovered a molecular switch that could potentially reverse drug resistance in aggressive prostate cancer. The protein-building molecule helped switch resistant prostate tumors back into a drug-sensitive state in experimental models. Many prostate cancer treatments target the androgen receptor, but tumors can become resistant to these treatments. This discovery offers a potential new target for future treatments.